UK IBD Microbiome Study
Professor Charlie Lees
Institution or company
University of Edinburgh
Inflammatory bowel disease (IBD) is a disease of the digestive tract that affects 1 in 250 of the UK population. The two main types are Crohn’s disease and ulcerative colitis. Despite major advances with medical therapy over the past twenty years, IBD remains incurable and an important cause of ill-health.
Over the last decade, doctors and scientists have made significant progress in understanding the causes of Crohn’s disease and ulcerative colitis, and we believe that these diseases may result from problems in the way the body’s immune or defence system interacts with the bacteria that live in the bowel.
This study aims to understand better the different types of bacteria that live in the bowels of people with and without inflammatory bowel disease. In particular, we hope to learn how the types of bacteria are influenced by differences in the genetic code of people who take part.
Participation: For this study we recruited 36 participants from the Cambridge BioResource to provide a stool sample.
Organisation: This study is organised by Dr Charlie Lees from the University of Edinburgh.